Skip to main content

Organovo Holdings, Inc. (ONVO)

NASDAQ: ONVO · IEX Real-Time Price · USD
7.11 -0.08 (-1.11%)
Sep 24, 2021 2:52 PM EDT - Market open
Market Cap60.68M
Revenue (ttm)n/a
Net Income (ttm)-16.59M
Shares Out8.71M
EPS (ttm)-2.23
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,855
Open7.05
Previous Close7.19
Day's Range6.98 - 7.14
52-Week Range6.05 - 23.92
Beta0.66
Analystsn/a
Price Target3.00 (-57.8%)
Est. Earnings DateNov 4, 2021

About ONVO

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug com...

IndustryBiotechnology
Founded2007
Employees9
Stock ExchangeNASDAQ
Ticker SymbolONVO
Full Company Profile

Financial Performance

Financial Statements

News

Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company's annual meeting of shareholders, on September 14, 2021, at 9:00 a.m. wa...

6 days ago - GlobeNewsWire

Catherine Wood's ARK Investment Slashes Organovo Holding

Catherine Wood ( Trades , Portfolio )'s ARK Investment Management has revealed a large reduction in the Organovo Holdings Inc. (NASDAQ:ONVO) position alongside a small reduction in the Syros Pharmaceuti...

Other symbols:SYRS
6 months ago - GuruFocus

Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONF...

SOLANA BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced it will be featured as a presenting company at the H.C. Wainwright Global Life Sciences C...

6 months ago - GlobeNewsWire

Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement

SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (“Organovo” or the “Company”) (Nasdaq: ONVO) announced today that it has regained compliance with the minimum bid price requiremen...

1 year ago - GlobeNewsWire

Organovo Announces One-for-Twenty Reverse Stock Split

SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (the “Company”) (Nasdaq: ONVO) today announced that it filed a certificate of second amendment to its certificate of incorporation ...

1 year ago - GlobeNewsWire

Will Organovo Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Organovo.

1 year ago - Zacks Investment Research

What Bargain Hunting ? Tap 5 Stocks With Rising P/E

Bet on these top-ranked stocks with rising P/E for outsized gains.

Other symbols:AVGRCYBRQLYS
1 year ago - Zacks Investment Research

Organovo (ONVO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Organovo (ONVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Organovo Acknowledges Receipt of Proposal

Reiterates Commitment to Strategic Review Process Reiterates Commitment to Strategic Review Process

1 year ago - GlobeNewsWire

Organovo (ONVO) Reports Q1 Loss, Lags Revenue Estimates

Organovo (ONVO) delivered earnings and revenue surprises of 0.00% and -13.13%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

2 years ago - Zacks Investment Research

Organovo (ONVO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Organovo (ONVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 years ago - Zacks Investment Research

Options Traders Expect Huge Moves in Organovo (ONVO) Stock

Organovo (ONVO) needs investors to pay close attention to the stock based on moves in the options market lately.

2 years ago - Zacks Investment Research

Organovo Holdings, Inc. (ONVO) CEO Taylor Crouch on Q4 2019 Results - Earnings Call Transcript

Organovo Holdings, Inc. (ONVO) CEO Taylor Crouch on Q4 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha